Our Team
Sean Corwen
Sean Corwen, a Director out of New York at SierraConstellation Partners, has a decade of experience as a turnaround professional in both advisory and operational roles. Sean devises and implements financial and/or operational restructuring strategies for clients in chapter 11 or in out-of-court workout situations. He has advised clients across a variety of industries, including consumer goods, energy, financial services, healthcare, media, and professional services.
In addition to providing analytical and operational support to clients in turnaround situations, Sean is skilled in managing chapter 11 processes and frequently oversees the provision of statements of financial affairs, schedules of assets and liabilities, monthly operating reports, contract and lease analyses and other court-related filings in complex situations.
Prior to joining SierraConstellation Partners, Sean co-founded an e-commerce platform to sell premium products direct-to-consumer. Before that, he worked as an investment banker focused on balance sheet restructuring, debt advisory and distressed M&A, advising both debtors and creditors in whole-business sales and financings. He began his career at Hall Capital Partners LLC, a San Francisco-based outsourced chief investment officer and multi-family office.
Sean holds an AB in Classics from the College of the Holy Cross and earned his MBA from the McDonough School of Business at Georgetown University. He previously held FINRA licenses Series 63 and Series 79.
Notable Assignments
- Financial advisor to clinical-stage pharmaceutical company with $200 million of funded debt. Supported finance and accounting team with liquidity management, budget forecasts and other analyses during pre-petition sales process. Provided support to legal counsel, investment bankers and other stakeholders during negotiation of restructuring support agreement, leading to successful asset sales and orderly chapter 11 plan of liquidation. Provided testimony with respect to plan feasibility during confirmation hearing.
- CRO support for multinational consumer services business. Completed four-wall and other analyses to advance marketing process. Provided support during liquidation process, including preparation of schedules/statements and other statutory reporting.
- Financial advisor to pharmaceutical company in its dual-track 363 sale of pre-clinical and commercial assets. Prepared schedules/statements, monthly operating reports, liquidation and other analyses filed with the court. Worked closely with management to optimize liquidity and monitor disbursements to vendors.
- CRO support for retail company and its successful sale and separation of retail and direct-to-consumer operations via chapter 11 plan of reorganization. Developed debtor-in-possession cash flow budget, providing a path to successful negotiation of plan support agreement with lenders and other stakeholders. Oversaw preparation of court-mandated reporting and liquidity management and analyses.
- Investment banker to consumer products company with >$450 million of pre-petition funded debt and multi-national operations. Prepared valuation analyses for disclosure statement and worked with senior bankers to prepare court declarations and negotiated with other creditors to ensure successful debt-for-equity swap in line with restructuring support agreement.
- Served as investment banker to non-debtor stakeholders in cases totaling >$20 billion of funded debt. Provided advice to official committees of unsecured creditors, the Pension Benefit Guaranty Corporation and other creditors in industries ranging from energy to media.
- Aided in portfolio management of 1.1bn fund of hedge funds; providing analytics, investor communication and portfolio rebalancing/new investment recommendations.
Media
- 22nd Annual M&A Advisor Awards, Healthcare/Life Sciences Deal of the Year (Bettween $100MM - $500MM) - Restructuring of Tricida, Inc.
- 15th Annual Americas Distressed M&A Deal of the Year (Middle Markets) - Therapeutics Inc acquires IP and related assets of Tricida Inc.
- 18th Annual Turnaround Awards Healthcare/Life Sciences Deal of the Yeart (Over $100MM) - Restructuring of Tricida, Inc.